Skip to main content
. 2020 Nov 19;6(4):191–198. doi: 10.1016/j.afos.2020.11.002

Table 2.

Adverse drug reactions.

n (%)
Number of all the patients 542
Number of patients with ADRs 57 (10.52)
Number of incidence of ADRs 81
Number of patients with serious ADRs
4 (0.74)
Number of incidence of serious ADRs 4
Common ADRs Serious ADRs
n (%) n (%)
Gastrointestinal disorders
Nausea 7 (1.29)
Abdominal pain upper 5 (0.92)
Diarrhea 4 (0.74)
Abdominal discomfort 3 (0.55)
Dyspepsia 3 (0.55)
Tooth ache 1 (0.18)
Musculoskeletal and connective tissue disorders
Arthralgia 3 (0.55)
Back pain 5 (0.92)
Osteonecrosis 1 (0.18)
General disorders and administration site conditions
Pyrexia 3 (0.55)
Injury, poisoning and procedural complications
Spinal compression fracture 4 (0.74)
Femur fracture 1 (0.18)
Surgical and medical procedures
Hospitalization 1 (0.18)

Values are presented as number (%).

ADRs, adverse drug reactions.

Common ADRs (≥ 3) and serious ADRs are presented.